Thus, a moderate increase in Cx43 to physiological levels may be more effective in the treatment of cardiovascular disease than excessive overexpression, as this may circumvent potential negative effects of increased Cx43 amounts. The gene discussed is GJA1; the disease is cardiovascular disorder.